• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧乳房切除术治疗乳腺肿瘤的猫围手术期去氨加压素的作用。

Effect of perioperative desmopressin in cats with mammary carcinoma treated with bilateral mastectomy.

机构信息

VCA Canada - Alta Vista Animal Hospital, Ottawa, Ontario, Canada.

Department of Veterinary Clinical Science, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.

出版信息

Vet Comp Oncol. 2021 Dec;19(4):724-734. doi: 10.1111/vco.12636. Epub 2020 Aug 11.

DOI:10.1111/vco.12636
PMID:32619339
Abstract

Perioperative administration of desmopressin has shown to significantly decrease rates of local recurrence and metastasis, and increase survival times in dogs with grade II and III mammary carcinomas. The objective of this study was to compare the oncologic outcome of cats with mammary carcinoma treated with bilateral mastectomy with or without perioperative administration of desmopressin. Medical records from nine veterinary institutions were searched to identify cats diagnosed with mammary carcinoma treated with bilateral mastectomy. Sixty cats treated with single-session or staged bilateral mastectomy were included. There were no significant differences in oncologic outcomes found between cats treated and not treated with desmopressin. No adverse effects were seen in any of the cats treated with perioperative desmopressin. Postoperative complications occurred in 18 cats (38.3%) treated with single-session bilateral mastectomy and in three cats (23.1%) treated with staged bilateral mastectomy (P = .48). Histologic grade and a modification of a proposed five-stage histologic staging system were both prognostic for disease-free interval. Incomplete histologic excision was associated with significantly increased rates of metastasis and tumour progression, and a shorter median survival time (MST). Cats that developed local recurrence also had a significantly shorter MST. The results of this study do not support the use of perioperative desmopressin to improve outcome when performing bilateral mastectomy for the treatment of mammary carcinoma in cats.

摘要

围手术期给予去氨加压素可显著降低 II 级和 III 级乳腺肿瘤犬的局部复发和转移率,并延长其生存时间。本研究的目的是比较行双侧乳房切除术且围手术期使用或不使用去氨加压素的猫的乳腺肿瘤的肿瘤学结果。通过检索 9 家兽医机构的病历,确定了接受双侧乳房切除术治疗的患有乳腺肿瘤的猫。共纳入 60 例接受单次或分期双侧乳房切除术治疗的猫。未发现去氨加压素治疗与未治疗的猫在肿瘤学结果方面存在差异。接受围手术期去氨加压素治疗的猫均未出现不良反应。行单次双侧乳房切除术的 18 只猫(38.3%)和分期双侧乳房切除术的 3 只猫(23.1%)出现了术后并发症(P=.48)。组织学分级和拟议的五阶段组织学分期系统的改良均是无病间隔的预后因素。不完全的组织学切除与转移和肿瘤进展的发生率显著增加以及中位生存时间(MST)显著缩短相关。发生局部复发的猫的 MST 也显著缩短。本研究结果不支持在猫行双侧乳房切除术治疗乳腺肿瘤时,使用围手术期去氨加压素来改善预后。

相似文献

1
Effect of perioperative desmopressin in cats with mammary carcinoma treated with bilateral mastectomy.双侧乳房切除术治疗乳腺肿瘤的猫围手术期去氨加压素的作用。
Vet Comp Oncol. 2021 Dec;19(4):724-734. doi: 10.1111/vco.12636. Epub 2020 Aug 11.
2
Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991-2014).乳腺腺癌猫的手术入路与并发症发生率、无进展生存时间和疾病特异性生存时间的相关性:107例病例(1991 - 2014年)
J Am Vet Med Assoc. 2018 Jun 1;252(11):1393-1402. doi: 10.2460/javma.252.11.1393.
3
Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade.围手术期辅助使用去氨加压素对局部晚期犬乳腺癌的影响及其与组织学分级的关系。
J Am Anim Hosp Assoc. 2011 Jan-Feb;47(1):21-7. doi: 10.5326/JAAHA-MS-5509. Epub 2010 Dec 16.
4
Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases.辅助多柔比星对比节拍式环磷酰胺和甲氨蝶呤对比手术单独用于治疗患有乳腺癌的猫:一项回顾性研究,涉及 137 例病例。
Vet Comp Oncol. 2021 Dec;19(4):714-723. doi: 10.1111/vco.12660. Epub 2020 Nov 9.
5
A prospective randomized trial of desmopressin in canine mammary carcinoma.一项去氨加压素治疗犬乳腺肿瘤的前瞻性随机试验。
Vet Comp Oncol. 2020 Dec;18(4):796-803. doi: 10.1111/vco.12619. Epub 2020 Jun 18.
6
Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study.围手术期使用去氨加压素可延长接受手术治疗的乳腺肿瘤母犬的生存期:一项初步研究。
Vet J. 2008 Oct;178(1):103-8. doi: 10.1016/j.tvjl.2007.06.015. Epub 2007 Aug 24.
7
Prognosis of malignant mammary tumor in 53 cats.53只猫恶性乳腺肿瘤的预后
J Vet Med Sci. 1996 Aug;58(8):723-6. doi: 10.1292/jvms.58.723.
8
Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.米托蒽醌辅助化疗用于接受根治性乳房切除术治疗的猫乳腺癌。
J Feline Med Surg. 2015 Dec;17(12):1000-4. doi: 10.1177/1098612X14567159. Epub 2015 Feb 11.
9
Effects of surgical wound infiltration with bupivacaine on postoperative analgesia in cats undergoing bilateral mastectomy.布比卡因手术伤口浸润对接受双侧乳房切除术的猫术后镇痛的影响。
J Vet Med Sci. 2014 Dec;76(12):1595-601. doi: 10.1292/jvms.14-0112. Epub 2014 Sep 20.
10
Neutrophil-to-lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas.中性粒细胞与淋巴细胞比值是猫乳腺肿瘤的独立预后标志物。
Vet Comp Oncol. 2021 Sep;19(3):482-491. doi: 10.1111/vco.12686. Epub 2021 Mar 15.

引用本文的文献

1
Prognostic Insights in Feline Mammary Carcinomas: Clinicopathological Factors and the Proposal of a New Staging System.猫乳腺肿瘤的预后见解:临床病理因素及新分期系统的提议
Animals (Basel). 2025 Mar 10;15(6):779. doi: 10.3390/ani15060779.
2
Repurposing Drugs in Small Animal Oncology.小动物肿瘤学中的药物再利用
Animals (Basel). 2022 Dec 29;13(1):139. doi: 10.3390/ani13010139.